List view / Grid view

Immuno-oncology

 

article

Combining autotaxin and TGF-β inhibitors in cancer

22 November 2023 | By

Dr Catherine Pickering, CEO of iOnctura, the clinical stage biopharmaceutical company delivering pioneering cancer treatments to patients with unmet medical needs, is at the forefront of cancer drug discovery. Dr Pickering and her team identify targets that have crucial roles in multiple tumour survival pathways, collaborate with world-renowned scientists and…